The DOI matches its Crossref record.
Sensitivity Improved Surface Plasmon Resonance Biosensor for Cancer Biomarker Detection Based on Plasmonic Enhancement
Abstract
In this study, we report the development of a nanoparticle-enhanced biosensor by integrating both the nanoparticles and immunoassay sensing technologies into a phase interrogation surface plasmon resonance (SPR) system for detecting antigen at a concentration as low as the femtomolar range. Our work has demonstrated that the plasmonic field extension generated from the gold film to gold nanorod (GNR) has led to a drastic sensitivity enhancement. Antibody-functionalized sensing film, together with antibody-conjugated GNRs, was readily served as a plasmonic coupling partner that can be used as a powerful ultrasensitive sandwich immunoassay for cancer-related disease detection. Experimentally, it was found that the bioconjugated GNR labels enhance the tumor necrosis factor alpha (TNF-α) antigen signal with more than 40-fold increase compared to the traditional SPR biosensing technique. The underlying principle was analyzed by simulating the near-field coupling between the sensing film and the GNR. The results have shown that GNRs were readily served as promising amplification labels in SPR sensing technology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Nanochemistry and Nanomedicine for Nanoparticle-based Diagnostics and Therapy
Chen, G., Roy, I., Yang, C., & Prasad, P. N. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00148 · Cited by 1,499
Self-citationNanomaterials enhanced surface plasmon resonance for biological and chemical sensing applications
Zeng, S., Baillargeat, D., Ho, H.-P., & Yong, K.-T. (2014) · Chemical Society Reviews · doi:10.1039/c3cs60479a · Cited by 1,230
Self-citationPlasmon-enhanced optical sensors: a review
Li, M., Cushing, S. K., & Wu, N. (2015) · The Analyst · doi:10.1039/c4an01079e · Cited by 1,011
Emerging advances in nanomedicine with engineered gold nanostructures
Webb, J. A., & Bardhan, R. (2014) · Nanoscale · doi:10.1039/c3nr05112a · Cited by 324
Malhotra, B. D., & Ali, M. A. (2018) · Nanomaterials for Biosensors · doi:10.1016/b978-0-323-44923-6.00001-7 · Cited by 319
Graphene–Gold Metasurface Architectures for Ultrasensitive Plasmonic Biosensing
Zeng, S., Sreekanth, K. V., Shang, J., Yu, T., Chen, C., Yin, F., Baillargeat, D., Coquet, P., Ho, H., Kabashin, A. V., et al. (2015) · Advanced Materials · doi:10.1002/adma.201501754 · Cited by 319
Self-citationBioanalytical Chemistry of Cytokines–a Review
Stenken, J. A., & Poschenrieder, A. J. (2015) · Analytica Chimica Acta · doi:10.1016/j.aca.2014.10.009 · Cited by 302
Trends and challenges of refractometric nanoplasmonic biosensors: A review
Estevez, M.-C., Otte, M. A., Sepulveda, B., & Lechuga, L. M. (2014) · Analytica Chimica Acta · doi:10.1016/j.aca.2013.10.048 · Cited by 301
Biomedical applications of metallic nanoparticles in cancer: Current status and future perspectives
Khursheed, R., Dua, K., Vishwas, S., Gulati, M., Jha, N. K., Aldhafeeri, G. M., Alanazi, F. G., Goh, B. H., Gupta, G., Paudel, K. R., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112951 · Cited by 286
Philip, A., & Kumar, A. R. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214424 · Cited by 281
Superparamagnetic nanoarchitectures for disease-specific biomarker detection
Masud, M. K., Na, J., Younus, M., Hossain, M. S. A., Bando, Y., Shiddiky, M. J. A., & Yamauchi, Y. (2019) · Chemical Society Reviews · doi:10.1039/c9cs00174c · Cited by 257
Chen, C., Law, W., Aalinkeel, R., Nair, B., Kopwitthaya, A., Mahajan, S. D., Reynolds, J. L., Zou, J., Schwartz, S. A., Prasad, P. N., et al. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200094 · Cited by 82
Self-citation
Metadata
- Authors
- Law, W.-C., Yong, K.-T., Baev, A., & Prasad, P. N.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2011-04-27
- Volume
- 5
- Issue
- 6
- Pages
- 4858-4864
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2319960298
- Cited by
- 289
- References
- 0
- FWCI
- 11.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.